These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 9753710)
1. Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. Ristow M; Müller-Wieland D; Pfeiffer A; Krone W; Kahn CR N Engl J Med; 1998 Oct; 339(14):953-9. PubMed ID: 9753710 [TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction. Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794 [TBL] [Abstract][Full Text] [Related]
3. 1,25(OH)2D3 inhibits bone marrow adipogenesis in senescence accelerated mice (SAM-P/6) by decreasing the expression of peroxisome proliferator-activated receptor gamma 2 (PPARgamma2). Duque G; Macoritto M; Kremer R Exp Gerontol; 2004 Mar; 39(3):333-8. PubMed ID: 15036392 [TBL] [Abstract][Full Text] [Related]
4. Differential regulation of peroxisome proliferator activated receptor gamma1 (PPARgamma1) and PPARgamma2 messenger RNA expression in the early stages of adipogenesis. Saladin R; Fajas L; Dana S; Halvorsen YD; Auwerx J; Briggs M Cell Growth Differ; 1999 Jan; 10(1):43-8. PubMed ID: 9950217 [TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor gamma 2 Pro12Ala gene variant is strongly associated with larger body mass in the Taiwanese. Lei HH; Chen MH; Yang WS; Chiu MC; Chen MC; Tai TY; Chuang LM Metabolism; 2000 Oct; 49(10):1267-70. PubMed ID: 11079814 [TBL] [Abstract][Full Text] [Related]
6. Regulation of activating transcription factor-2 in early stage of the adipocyte differentiation program. Lee MY; Kong HJ; Cheong J Biochem Biophys Res Commun; 2001 Mar; 281(5):1241-7. PubMed ID: 11243868 [TBL] [Abstract][Full Text] [Related]
8. Subcutaneous abdominal preadipocyte differentiation in vitro inversely correlates with central obesity. Permana PA; Nair S; Lee YH; Luczy-Bachman G; Vozarova De Courten B; Tataranni PA Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E958-62. PubMed ID: 14970008 [TBL] [Abstract][Full Text] [Related]
9. Binge eating as a major phenotype of melanocortin 4 receptor gene mutations. Branson R; Potoczna N; Kral JG; Lentes KU; Hoehe MR; Horber FF N Engl J Med; 2003 Mar; 348(12):1096-103. PubMed ID: 12646666 [TBL] [Abstract][Full Text] [Related]
10. Pro12Ala missense mutation of the peroxisome proliferator activated receptor gamma and diabetes mellitus. Ringel J; Engeli S; Distler A; Sharma AM Biochem Biophys Res Commun; 1999 Jan; 254(2):450-3. PubMed ID: 9918859 [TBL] [Abstract][Full Text] [Related]
11. Induction of the nuclear orphan receptor RORgamma during adipocyte differentiation of D1 and 3T3-L1 cells. Austin S; Medvedev A; Yan ZH; Adachi H; Hirose T; Jetten AM Cell Growth Differ; 1998 Mar; 9(3):267-76. PubMed ID: 9543393 [TBL] [Abstract][Full Text] [Related]
12. Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. Clément K; Vaisse C; Manning BS; Basdevant A; Guy-Grand B; Ruiz J; Silver KD; Shuldiner AR; Froguel P; Strosberg AD N Engl J Med; 1995 Aug; 333(6):352-4. PubMed ID: 7609752 [TBL] [Abstract][Full Text] [Related]
13. Regulation of human skeletal stem cells differentiation by Dlk1/Pref-1. Abdallah BM; Jensen CH; Gutierrez G; Leslie RG; Jensen TG; Kassem M J Bone Miner Res; 2004 May; 19(5):841-52. PubMed ID: 15068508 [TBL] [Abstract][Full Text] [Related]
14. Differential effects of adiposity on peroxisomal proliferator-activated receptor gamma1 and gamma2 messenger ribonucleic acid expression in human adipocytes. Sewter C; Blows F; Considine R; Vidal-Puig A; O'Rahilly S J Clin Endocrinol Metab; 2002 Sep; 87(9):4203-7. PubMed ID: 12213872 [TBL] [Abstract][Full Text] [Related]
15. Missense variants in the human peroxisome proliferator-activated receptor-gamma2 gene in lean and obese subjects. Hamann A; Münzberg H; Buttron P; Büsing B; Hinney A; Mayer H; Siegfried W; Hebebrand J; Greten H Eur J Endocrinol; 1999 Jul; 141(1):90-2. PubMed ID: 10407229 [TBL] [Abstract][Full Text] [Related]
16. The Pro115Gln polymorphism within the PPAR gamma2 gene has no epidemiological impact on morbid obesity. Hamer OW; Forstner D; Ottinger I; Ristow M; Bollheimer LC; Schölmerich J; Palitzsch KD Exp Clin Endocrinol Diabetes; 2002 Aug; 110(5):230-4. PubMed ID: 12148087 [TBL] [Abstract][Full Text] [Related]
17. Significance of Pro12Ala mutation in peroxisome proliferator-activated receptor-gamma2 in Korean diabetic and obese subjects. Oh EY; Min KM; Chung JH; Min YK; Lee MS; Kim KW; Lee MK J Clin Endocrinol Metab; 2000 May; 85(5):1801-4. PubMed ID: 10843155 [TBL] [Abstract][Full Text] [Related]
18. The Pro115Gln and Pro12Ala PPAR gamma gene mutations in obesity and type 2 diabetes. Clement K; Hercberg S; Passinge B; Galan P; Varroud-Vial M; Shuldiner AR; Beamer BA; Charpentier G; Guy-Grand B; Froguel P; Vaisse C Int J Obes Relat Metab Disord; 2000 Mar; 24(3):391-3. PubMed ID: 10757637 [TBL] [Abstract][Full Text] [Related]
19. The Pro12Ala PPARgamma2 gene missense mutation is associated with obesity and insulin resistance in Swedish middle-aged men. Rosmond R; Chagnon M; Bouchard C Diabetes Metab Res Rev; 2003; 19(2):159-63. PubMed ID: 12673785 [TBL] [Abstract][Full Text] [Related]
20. Frequency and significance of Pro12Ala and Pro115Gln polymorphism in gene for peroxisome proliferation-activated receptor-gamma regarding metabolic parameters in a Caucasian cohort. Schäffler A; Barth N; Schmitz G; Zietz B; Palitzsch KD; Schölmerich J Endocrine; 2001 Apr; 14(3):369-73. PubMed ID: 11444435 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]